Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Smart Women's Choice
WARNING LETTER
•Smart Women's Choice•May 25, 2021

Smart Women's Choice – FDA Warning Letter, May 25, 2021

Record Details

The FDA issued a Warning Letter to Dr. Farron after reviewing product labeling and websites (smartwomenschoice.com, Facebook, Instagram) from February to April 2021 for the product “Smart Women’s Choice.” The FDA determined that claims made on these platforms establish the product as an unapproved new drug. The product is intended for use in disease prevention or to affect body function, specifically as a contraceptive, with claims such as "natural birth control that cannot fail" and that it "immobilizes the sperm." These claims classify it as a "drug" under section 201(g)(1) of the FD&C Act. Moreover, it is deemed a "new drug" under section 201(p) because it is not generally recognized as safe and effective for its intended uses. Introducing or delivering unapproved new drugs into interstate commerce without prior FDA approval violates sections 301(d) and 505(a) of the FD&C Act, and no FDA-approved applications exist for “Smart Women’s Choice.” The FDA requires a written response within fifteen working days detailing specific corrective actions taken, steps to prevent recurrence, and supporting documentation. Failure to adequately address these violations may result in legal action, including seizure and/or injunction.

Company
Smart Women's Choice
Inspection date
May 25, 2021
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Carolyn E. Becker
View Company Profile

ID · f52dc806-69f1-4439-824a-d71796f8a3a5

Violation Codes4
21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Smart Women's Choice
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.